Polysaccharide processing and presentation by the MHCII pathway

Cell

Volumn 117, Issue 5, 2004, Pages 677-687

  Cobb, Brian A ^a,b   Wang, Qun ^a,b   Tzianabos, Arthur O ^a   Kasper, Dennis L ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC; CARBOHYDRATE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE; PEPTIDE; POLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL MEMBRANE; CELL ACTIVATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 2542507286     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2004.05.001     Document Type: Article

References (47)

1. Abbas A.K., Lichtman A.H., Pober J.S. Cellular and Molecular Immunology. 2000;W.B. Saunders Company, New York
2. Accolla R.S., Carra G., Buchegger F., Carrel S., Mach J.P. The human Ia-associated invariant chain is synthesized in Ia-negative B cell variants and is not expressed on the cell surface of both Ia-negative and Ia-positive parental cells. J. Immunol. 134:1985;3265-3271
3. Adorini L., Ullrich S.J., Appella E., Fuchs S. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells. Nature. 346:1990;63-66
4. Bacci S., Nakamura T., Streilein J.W. Failed antigen presentation after UVB radiation correlates with modifications of Langerhans cell cytoskeleton. J. Invest. Dermatol. 107:1996;838-843
5. Baker C.J., Paoletti L.C., Wessels M.R., Guttormsen H.K., Rench M.A., Hickman M.E., Kasper D.L. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J. Infect. Dis. 179:1999;142-150
6. Brubaker J.O., Li Q., Tzianabos A.O., Kasper D.L., Finberg R.W. Mitogenic activity of purified capsular polysaccharide A from Bacteroides fragilis. differential stimulatory effect on mouse and rat lymphocytes in vitro J. Immunol. 162:1999;2235-2242
7. Busch R., Reich Z., Zaller D.M., Sloan V., Mellins E.D. Secondary structure composition and pH-dependent conformational changes of soluble recombinant HLA-DM. J. Biol. Chem. 273:1998;27557-27564
8. Choi Y.H., Roehrl M.H., Kasper D.L., Wang J.Y. A unique structural pattern shared by T-cell-activating and abscess-regulating zwitterionic polysaccharides. Biochemistry. 41:2002;15144-15151
9. Chung D.R., Kasper D.L., Panzo R.J., Chtinis T., Grusby M.J., Sayegh M.H., Tzianabos A.O. CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J. Immunol. 170:2003;1958-1963
10. D'Souza M.P., August J.T. A kinetic analysis of biosynthesis and localization of a lysosome-associated membrane glycoprotein. Arch. Biochem. Biophys. 249:1986;522-532
11. Davies G., Henrissat B. Structures and mechanisms of glycosyl hydrolases. Structure. 3:1995;853-859
12. Edmunds N.J., Marshall J.M. The roles of nitric oxide in dilating proximal and terminal arterioles of skeletal muscle during systemic hypoxia. J. Vasc. Res. 40:2003;68-76
13. Forman H.J., Torres M. Redox signaling in macrophages. Mol. Aspects Med. 22:2001;189-216
14. Gantt K.R., Goldman T.L., McCormick M.L., Miller M.A., Jeronimo S.M., Nascimento E.T., Britigan B.E., Wilson M.E. Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J. Immunol. 167:2001;893-901
15. Gauthier L., Smith K.J., Pyrdol J., Kalandadze A., Strominger J.L., Wiley D.C., Wucherpfennig K.W. Expression and crystallization of the complex of HLA-DR2 (DRA, DRB1*1501) and an immunodominant peptide of human myelin basic protein. Proc. Natl. Acad. Sci. USA. 95:1998;11828-11833
16. Kalka-Moll W.M., Tzianabos A.O., Wang Y., Carey V.J., Finberg R.W., Onderdonk A.B., Kasper D.L. Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity. J. Immunol. 164:2000;719-724
17. Kalka-Moll W.M., Tzianabos A.O., Bryant P.W., Niemeyer M., Ploegh H.L., Kasper D.L. Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions. J. Immunol. 169:2002;6149-6153
18. Kappler J., White J., Kozono H., Clements J., Marrack P. Binding of a soluble alpha beta T-cell receptor to superantigen/major histocompatibility complex ligands. Proc. Natl. Acad. Sci. USA. 91:1994;8462-8466
19. Kasper D.L., Paoletti L.C., Wessels M.R., Guttormsen H.K., Carey V.J., Jennings H.J., Baker C.J. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J. Clin. Invest. 98:1996;2308-2314
20. Koh S.D., Monaghan K., Sergeant G.P., Ro S., Walker R.L., Sanders K.M., Horowitz B. TREK-1 regulation by nitric oxide and cGMP-dependent protein kinase. An essential role in smooth muscle inhibitory neurotransmission. J. Biol. Chem. 276:2001;44338-44346
21. Krinos C.M., Coyne M.J., Weinacht K.G., Tzianabos A.O., Kasper D.L., Comstock L.E. Extensive surface diversity of a commensal microorganism by multiple DNA inversions. Nature. 414:2001;555-558
22. Laubach V.E., Shesely E.G., Smithies O., Sherman P.A. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. USA. 92:1995;10688-10692
23. Mosyak L., Zaller D.M., Wiley D.C. The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation. Immunity. 9:1998;377-383
24. Pier G.B., Elcock M.E. Nonspecific immunoglobulin synthesis and elevated IgG levels in rabbits immunized with mucoid exopolysaccharide from cystic fibrosis isolates of Pseudomonas aeruginosa. J. Immunol. 133:1984;734-739
25. Pollock J.D., Williams D.A., Gifford M.A., Li L.L., Du X., Fisherman J., Orkin S.H., Doerschuk C.M., Dinauer M.C. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet. 9:1995;202-209
26. Riberdy J.M., Newcomb J.R., Surman M.J., Barbosa J.A., Cresswell P. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature. 360:1992;474-477
27. Riese R.J., Mitchell R.N., Villadangos J.A., Shi G.P., Palmer J.T., Karp E.R., De Sanctis G.T., Ploegh H.L., Chapman H.A. Cathepsin S activity regulates antigen presentation and immunity. J. Clin. Invest. 101:1998;2351-2363
28. Rotzschke O., Lau J.M., Hofstatter M., Falk K., Strominger J.L. A pH-sensitive histidine residue as control element for ligand release from HLA-DR molecules. Proc. Natl. Acad. Sci. USA. 99:2002;16946-16950
29. Rye C.S., Withers S.G. Glycosidase mechanisms. Curr. Opin. Chem. Biol. 4:2000;573-580
30. Sanderson F., Kleijmeer M.J., Kelly A., Verwoerd D., Tulp A., Neefjes J.J., Geuze H.J., Trowsdale J. Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science. 266:1994;1566-1569
31. Schroter C.J., Braun M., Englert J., Beck H., Schmid H., Kalbacher H. A rapid method to separate endosomes from lysosomal contents using differential centrifugation and hypotonic lysis of lysosomes. J. Immunol. Methods. 227:1999;161-168
32. Shi G.P., Munger J.S., Meara J.P., Rich D.H., Chapman H.A. Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J. Biol. Chem. 267:1992;7258-7262
33. Shi G.P., Villadangos J.A., Dranoff G., Small C., Gu L., Haley K.J., Riese R., Ploegh H.L., Chapman H.A. Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity. 10:1999;197-206
34. Sloan V.S., Cameron P., Porter G., Gammon M., Amaya M., Mellins E., Zaller D.M. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature. 375:1995;802-806
35. Svensson M., Stockinger B., Wick M.J. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells. J. Immunol. 158:1997;4229-4236
36. Tsuji S., Taniuchi S., Hasui M., Yamamoto A., Kobayashi Y. Increased nitric oxide production by neutrophils from patients with chronic granulomatous disease on trimethoprim-sulfamethoxazole. Nitric Oxide. 7:2002;283-288
37. Tzianabos A.O., Kasper D.L. Role of T cells in abscess formation. Curr. Opin. Microbiol. 5:2002;92-96
38. Tzianabos A.O., Pantosti A., Baumann H., Brisson J.R., Jennings H.J., Kasper D.L. The capsular polysaccharide of Bacteroides fragilis comprises two ionically linked polysaccharides. J. Biol. Chem. 267:1992;18230-18235
39. Tzianabos A.O., Onderdonk A.B., Rosner B., Cisneros R.L., Kasper D.L. Structural features of polysaccharides that induce intra-abdominal abscesses. Science. 262:1993;416-419
40. Tzianabos A.O., Onderdonk A.B., Zaleznik D.F., Smith R.S., Kasper D.L. Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation. Infect. Immun. 62:1994;4881-4886
41. Tzianabos A.O., Russell P.R., Onderdonk A.B., Gibson F.C. III, Cywes C., Chan M., Finberg R.W., Kasper D.L. IL-2 mediates protection against abscess formation in an experimental model of sepsis. J. Immunol. 163:1999;893-897
42. Tzianabos A.O., Finberg R.W., Wang Y., Chan M., Onderdonk A.B., Jennings H.J., Kasper D.L. T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria. J. Biol. Chem. 275:2000;6733-6740
43. Tzianabos A.O., Wang J.Y., Lee J.C. Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides. Proc. Natl. Acad. Sci. USA. 98:2001;9365-9370
44. Wang Y., Kalka-Moll W.M., Roehrl M.H., Kasper D.L. Structural basis of the abscess-modulating polysaccharide A2 from Bacteroides fragilis. Proc. Natl. Acad. Sci. USA. 97:2000;13478-13483
45. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 15:1997;821-850
46. Watts C., Powis S. Pathways of antigen processing and presentation. Rev. Immunogenet. 1:1999;60-74
47. Wiman K., Claesson L., Rask L., Tragardh L., Peterson P.A. Purification and partial amino acid sequence of papain-solubilized class II transplantation antigens. Biochemistry. 21:1982;5351-5358